Nitric oxide, heparin and procaine treatment in experimental ceruleine-induced acute pancreatitis in rats

Archivum Immunologiae et Therapiae Experimentalis

Volumn 47, Issue 3, 1999, Pages 155-160

  Dobosz, Marek ^a   Wajda, Zdzisław ^a   Hać, Stanisław ^a   Myśliwska, Jolanta ^a   Bryl, Ewa ^a   Mionskowska, Lucjanna ^a   Roszkiewicz, Andrzej ^a   Myśliwski, Andrzej ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Acute pancreatitis; Heparin; Interleukin 6; Microcirculation; Nitric oxide; Procaine

Indexed keywords

ARGININE; CERULETIDE; HEPARIN; INTERLEUKIN 6; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PROCAINE;

ACINAR CELL; ACUTE PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY BLOOD; CELL VACUOLE; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICROCIRCULATION; NONHUMAN; PANCREAS BLOOD FLOW; PANCREAS NECROSIS; PANCREAS PERFUSION; RAT;

ACUTE DISEASE; ANIMALS; ARGININE; CAERULEIN; HEPARIN; INTERLEUKIN-6; MALE; MICROCIRCULATION; NITRIC OXIDE; NITROARGININE; PANCREAS; PANCREATITIS; PROCAINE; RATS; RATS, WISTAR;

EID: 0033033878     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. AISAKA K., GROSS S. S., GRIFFITH O. W. and LEVI R. (1989): NG-methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent presser agent in the guinea pig: does nitric oxide regulate blood pressure in vivo? Biochem. Biophys. Res. Comun., 160, 881-886.
2. BECKMAN J. S., BECKMAN T. W., CHEN J., MARSHALL P. A. and FREEMAN B. A. (1990): Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from NO and Superoxide. Proc. Natl. Acad. Sci. USA, 87, 1620-1624.
3. CASADEVALL M., PANES J., PIQUE J. M., BOSCH J., TERES J. and RODES J. (1992): Limitations of laser-Doppler velocimetry and reflectance spectrophotometry in estimating gastric mucosal blood flow. Am. J. Physiol., 263, G810-G815.
4. DALE W. A. and ROCHESTER N. Y. (1952): Splanchnic block in the treatment of acute pancreatitis. Surgery, 32, 605-614.
5. DłUGOSZ J., BAJKO K. and GABRYELEWICZ A. (1979): The effect of heparin on lysosomes of the dog pancreas during acute experimental pancreatitis. Exp. Pathol., 17, 237-241.
6. FURUKAWA M., KIMURA T., SUMII T., YAMAGUSCHI H. and NAWATA H. (1993): Role of local pancreatic blood flow in development of hemorrhagic pancreatitis induced by stress in rats. Pancreas, 8, 499-505.
7. GABRYELEWICZ A., KOSIDłO S., PROKOPOWICZ J. and PODKOWICZ K. (1986): Does heparin modify protease-antiprotease balance in acute experimental pancreatitis in rats. Hepatoga-stroenterology, 33, 79-82.
8. GABRYELEWICZ A., NIEWIAROWSKI S., PROKOPOWICZ J. and CHLEBOWSKI J. (1969): Heparin and protease inhibitors in the prevention of experimental acute pancreatic necrosis in dogs. Digestion, 2, 7-16.
9. GOODHEAD B. and WRIGHT P. W. (1969): The effect of postganglionic sympathectomy on the development of hemorrhagic pancreatitis in the dog. Ann. Surg., 170, 951-960.
10. GOULBOURNE I. A., WATSON H. and DAVIES G. C. (1987): 111In-platelet and 125I-fibrinogen deposition in the lungs in experimental acute pancreatitis. J. Surg. Res., 43, 521-526.
11. GROSS V., LESER H.-G., HEINISCH A. and SCHOLMERICH J. (1993): Inflammatory mediators and cytokines - new aspects of the pathophysiology and assessment of severity of acute pancreatitis? Hepatogastroenterology, 40, 522-530.
12. HEATH D. I., CRUICKSHANK A., GUDGEON M., JEHANLI A., SHENKIN A. and IMRIE C. W. (1993): Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut, 34, 41-45.
13. HUCH K., SCHMIDT J., SCHRATT W., SINN H. P., BUHR H., HERFARTH C. and KLAR E. (1995): Hyperoncotic dextran and systemic aprotinin in necrotizing rodent pancreatitis. Scand. J. Gastroenterol., 30, 812-816.
14. IMAI T., HIRATA Y., EMAI T. and MARUMO F. (1993): Heparin has an inhibitory effect on endothelin-1 synthesis and release by endothelial cells. Hypertension, 21, 353-358.
15. KELLY D. M., MCENTEE G. P., MCGEENEY K. F. and FITZPATRICK J. M. (1993): Microvasculature of the pancreas, liver, and kidney in cerulein-induced pancreatitis. Arch. Surg., 128, 293-295.
16. KLAR E., MESSMER K., WARSHAW A. L. and HERFARTH C. (1990): Pancreatic ischaemia in experimental acute pancreatitis: mechanism, significance and therapy. Br. J. Surg., 77, 1205-1210.
17. KLAR E., RATTNER D. W., COMPTON C., STANFORD G., CHERNOW B. and WARSHAW A. L. (1991): Adverse effect of therapeutic vasoconstrictors in experimental acute pancreatitis. Ann. Surg., 214, 168-174.
18. KLAR E., SCHRATT W., FOITZIK T., BUHR H., HERFARTH C. and MESSMER K. (1994): Impact of microcirculatory flow pattern changes on the development of acute edematous and necrotizing pancreatitis in rabbit pancreas. Dig. Dis. Sci., 39, 2639-2644.
19. KONTUREK S. J., SZLACHCIC A., DEMBIŃSKI A., WARZECHA Z., JAWOREK J. and STACHURA J. (1994): Nitric oxide in pancreatic secretion and hormone induced pancreatitis in rats. Int. J. Pancreatol., 15, 19-28.
20. KYOGOKU T., MANABE T. and TOBE T. (1992): Role of ischemia in acute pancreatitis. Hemorrhagic shock converts edematous pancreatitis to hemorrhagic pancreatitis in rats. Dig. Dis. Sci., 37, 1409-1417.
21. LEHTOLA A., TALJA M., PUOLAKKAINEN P., NORDLING S. and SCHRODER T. (1987): Peritoneal lavage combined with volume therapy in porcine hemorrhagic pancreatitis. Effects on hemodynamics, microcirculation, and peritoneal morphology. Scand. J. Gastroenterol., 22, 559-567.
22. LIU X. H., KIMURA T., ISHIKAWA H., YAMAGUCHI H., FURUKAWA M., NAKANO I., KINJOH M. and NAWATA H. (1995): Effect of endothelin-1 on the development of hemorrhagic pancreatitis in rats. Scand. J. Gastroenterol., 30, 276-282.
23. Liu X. H., NAKANO I., YAMAGUCHI H., ITO T., GOTO M., KOYANAGI S., KINJOH M. and NAWATA H. (1995): Protective effect of nitric oxide on defelopment of acute pancreatitis in rats. Dig. Dis. Sci., 40, 2162-2169.
24. LUCIO J., D'BROT J. and GUO C.-B. (1992): Immunologic mast cell-mediated responses and histamine release and attenuated by heparin. J. Appl. Physiol., 73, 1093-2101.
25. MONCADA S., PALMER R. M. J. and HIGGS E. A. (1991): Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev., 43, 109-141.
26. NEVALAINEN T. J. (1988): Phospholipase A2 in acute pancreatitis. Scand. J. Gastroenterol., 23, 897-904.
27. POPPER H. L., NECHELES H. and RUSSEL K. C. (1948): Transition of pancreatic edema into ancreatic necrosis. Surg. Gynecol. Obstet., 87, 79-82.
28. RADOMSKI M. W., PALMER R. M. J. and MONCADA S. (1987): The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem. Biophys. Res. Commun., 148, 1482-1489.
29. RUBANYI G. M., Ho E. H., CANTOR E. H., LUMMA W. C. and PARKER BOTELHO L. H. (1991): Cytoprotective function of nitric oxide: inactivation of superoxide radicals produced by human leukocyte. Biochem. Biophys. Res. Commun., 181, 1392-1397.
30. STERNBERG W. C. III, MAKHOUL R. G. and ADELMAN B. (1993): Heparin prevents postischemic endothelial cell dysfunction by a mechanism independent of its anticoagulant activity. J. Vasc. Surg., 17, 318-327.
31. WEILER J. M., EDENS R. E., LINHARDT R. J. and KAPELANSKI D. P. (1992): Heparin and modified heparin inhibit complement activation in vivo. J. Immunol., 148, 127-131.
32. YAMAGUSCHI H., KIMURA T. and NAWATA H. (1990): Does stress play a role in the development of severe pancratitis in rats? Gastroenterology, 98, 1682-1688.